The term ‘cancer’ refers to a group of disorders characterized by the uncontrolled growth and spread of abnormal cells. These cells can invade tissues and also metastasize, meaning they can spread to distant parts of…
A New Way to Stop Tumors? Scientists Disable Cancer’s ‘Power Hubs’
Within tumor cells, researchers found that RNA constructs droplet-like power hubs that function as growth control centers. Researchers revealed it in a rare form of kidney cancer patients. They were finally able to completely stop the progression of cancer. They achieved this by creating a molecular switch that destroys these hubs.
The term ‘cancer’ refers to a group of disorders characterized by the uncontrolled growth and spread of abnormal cells. These cells can invade tissues and also metastasize, meaning they can spread to distant parts of the body. They also disrupt normal bodily functions. Cancer often begins with DNA mutations in cells. These mutations finally cause rapid and abnormal cell division. While some cases are caused by genetics, most are linked to lifestyle factors. These include tobacco use, diet, as well as alcohol consumption. Environmental factors also play a significant role.
Lei Guo, Rongjie Zhao et al. conducted this research and published it under the title “RNA-mediated condensation of TFE3 oncofusions facilitates transcriptional hub formation to promote translocation renal cell carcinoma” in September 2025.
ENTECH STEM Magazine has included this research in its list of the Top 10 Biotechnology Discoveries and Innovations of 2025.
Potential Benefits Of Disabling Cancer’s Power Hubs
Improved Treatment Options for Kidney Cancer Patients
- This innovative approach offers a potential new treatment option. The treatment of disabling power hubs targets patients with a rare type of kidney cancer that depends on these RNA-based growth hubs.
- Access to this targeted therapy can give patients as well as their families renewed hope. It can also increase their confidence in the treatment plan. These benefits can significantly improve overall well-being and quality of life.
Enhanced Survival Rates and Reduced Mortality
- By successfully disrupting the RNA-based growth control centers and power hubs in the cancer cells, this molecular switch-based therapy has the potential to improve clinical outcomes and also increase survival rates for patients with this rare form of kidney cancer.
- Improved treatment options and better clinical outcomes can allow patients to spend more quality time with their loved ones and participate more actively in their daily lives.
Advancement in Personalized and Precision Medicine
- The development of this targeted therapy, which specifically addresses the unique characteristics of the rare kidney cancer, represents progress in the field of personalized and precision medicine.
- This approach can inspire further research and innovation in the development of targeted therapies for other types of cancer, ultimately leading to a more personalized and effective approach to cancer care.
Educational and Career Opportunities
RNA Biology and Cancer Metabolism
- Researchers are investigating how the RNA-based droplet-like hubs are formed. They are also studying how these hubs function as growth control centers in rare kidney cancer cells.
- Exploring the role of RNA dynamics, phase separation, and liquid-liquid phase transitions in the regulation of cancer cell signaling and proliferation
- Studying the metabolic dependencies and vulnerabilities of cancer cells that rely on these RNA-based growth control hubs
Molecular Engineering and Drug Design
- Designing and optimizing the molecular switch, including the development of specific targeting moieties, to effectively disrupt the RNA-based hubs in the cancer cells
- Exploring the potential for rational drug design and computational modeling to guide the engineering of more potent and selective molecular switches
- Investigating the delivery methods and formulations to enhance the efficacy and specificity of the molecular switch-based therapy
Biomarker Discovery and Precision Diagnostics
- Identifying specific biomarkers or molecular signatures that can reliably identify the rare kidney cancer subtype that relies on the RNA-based growth hubs
- Developing companion diagnostic tests or multimodal approaches to select the most appropriate patients who are likely to benefit from the molecular switch-based therapy
- Integrating the molecular switch-based treatment into personalized cancer care strategies that consider the unique genetic and molecular profiles of individual patients
Reference
Guo, L., Zhao, R., Lee, YT. et al. RNA-mediated condensation of TFE3 oncofusions facilitates transcriptional hub formation to promote translocation renal cell carcinoma. Nat Commun 16, 8712 (2025). https://doi.org/10.1038/s41467-025-63761-z
Additionally, to stay updated with the latest developments in STEM research, visit ENTECH Online. Basically, this is our digital magazine for science, technology, engineering, and mathematics. Also, at ENTECH Online, you’ll find a wealth of information.
- Author
- Latest Posts
I have completed my Master’s in Zoology and am a passionate, curiosity-driven science enthusiast aiming to transform complex scientific ideas in a manner that are easy to understand hence, educate, and inspire.
My journey began with an inherent fascination for understanding how life works at the molecular, cellular, and systemic levels. Over time, this curiosity expanded into a desire to share that understanding with others through clear, engaging communication.
I have an experience of working on the projects in the field of Entomology which has provided me hands-on experience with various research techniques. Besides, I have also gained experience of lab work as well as developed communication skills during the course of my bachelors and masters.
With a strong foundation in life sciences and a growing interest in Medical and Biological research, I have cultivated a writing style that merges scientific facts with creativity.
My experience in teaching has also taught me has also taught me to develop an understanding of what are the interests of people and how to communicate them effectively.
I am also committed to lifelong learning, actively engaging in Interdisciplinary learning, so as to broaden my perspective.
